PTO user fee retention for patent review included in Coble bill (HR 400) passed by subcommittee.
PTO USER FEE RETENTION LEGISLATION INCORPORATED INTO OMNIBUS patent legislation at a Mar. 5 mark-up of the House Judiciary/Intellectual Property Subcommittee. Subcommittee Chairman Coble's (R-N.C.) "Patent System Improvement Act" (HR 400) now includes a previously separate Coble measure (HR 673) permitting the Patent & Trademark Office to use all of its user fees on patent and trademark reviews. President Clinton's FY 1998 budget proposal would divert $92 mil. in PTO user fees to other government programs, up from $54 mil. in FY 1997 ("The Pink Sheet" March 3, T&G-4).
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth